Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Inhibition of tumor angiogenesis by cannabinoids.

Blázquez C, Casanova ML, Planas A, Gómez Del Pulgar T, Villanueva C, Fernández-Aceñero MJ, Aragonés J, Huffman JW, Jorcano JL, Guzmán M.

FASEB J. 2003 Mar;17(3):529-31. Epub 2003 Jan 2.

PMID:
12514108
2.

Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.

Zhang L, Yang N, Park JW, Katsaros D, Fracchioli S, Cao G, O'Brien-Jenkins A, Randall TC, Rubin SC, Coukos G.

Cancer Res. 2003 Jun 15;63(12):3403-12.

3.

Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.

Casanova ML, Blázquez C, Martínez-Palacio J, Villanueva C, Fernández-Aceñero MJ, Huffman JW, Jorcano JL, Guzmán M.

J Clin Invest. 2003 Jan;111(1):43-50.

4.

Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.

Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G.

J Clin Invest. 2002 Mar;109(6):777-85.

5.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
6.

Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.

Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM.

Nat Med. 2003 Aug;9(8):1026-32. Epub 2003 Jul 20.

PMID:
12872165
7.

Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).

Kim JS, Chang JH, Yu HK, Ahn JH, Yum JS, Lee SK, Jung KH, Park DH, Yoon Y, Byun SM, Chung SI.

J Biol Chem. 2003 Aug 1;278(31):29000-8. Epub 2003 May 13.

8.

Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.

Giavazzi R, Sennino B, Coltrini D, Garofalo A, Dossi R, Ronca R, Tosatti MP, Presta M.

Am J Pathol. 2003 Jun;162(6):1913-26.

9.

Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells.

Uneda S, Matsuno F, Sonoki T, Tniguchi I, Kawano F, Hata H.

Haematologica. 2003 Jan;88(1):113-5. No abstract available.

10.

Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.

Keyes KA, Mann L, Cox K, Treadway P, Iversen P, Chen YF, Teicher BA.

Cancer Chemother Pharmacol. 2003 Apr;51(4):321-7. Epub 2003 Mar 18.

PMID:
12721760
11.

Vascular endothelial growth factor and angiopoietin 2 expression in laser-treated choroidal neovascular membranes.

Otani A, Takagi H, Oh H, Koyama S, Sugita G, Ogura Y.

Retina. 2003 Jun;23(3):402-4. No abstract available.

PMID:
12824844
12.

Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.

Bruns CJ, Liu W, Davis DW, Shaheen RM, McConkey DJ, Wilson MR, Bucana CD, Hicklin DJ, Ellis LM.

Cancer. 2000 Aug 1;89(3):488-99.

PMID:
10931447
13.

Biomedical significance of endothelial cell specific growth factor, angiopoietin.

Koh GY, Kim I, Kwak HJ, Yun MJ, Leem JC.

Exp Mol Med. 2002 Mar 31;34(1):1-11. Review.

14.
15.

The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.

Hajitou A, Grignet C, Devy L, Berndt S, Blacher S, Deroanne CF, Bajou K, Fong T, Chiang Y, Foidart JM, Noël A.

FASEB J. 2002 Nov;16(13):1802-4. Epub 2002 Sep 19.

PMID:
12354694
16.

Decorin suppresses tumor cell-mediated angiogenesis.

Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV.

Oncogene. 2002 Jul 18;21(31):4765-77.

17.
18.

Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.

Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J.

Mol Cancer Res. 2002 Nov;1(1):2-11.

19.

Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.

Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.

Cancer Res. 2002 Dec 1;62(23):6884-90.

20.

Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity.

Mu J, Abe Y, Tsutsui T, Yamamoto N, Tai XG, Niwa O, Tsujimura T, Sato B, Terano H, Fujiwara H, Hamaoka T.

Jpn J Cancer Res. 1996 Sep;87(9):963-71.

PMID:
8878460

Supplemental Content

Support Center